213 related articles for article (PubMed ID: 26772439)
1. Amyloid imaging using fluorine-19 magnetic resonance imaging ((19)F-MRI).
Tooyama I; Yanagisawa D; Taguchi H; Kato T; Hirao K; Shirai N; Sogabe T; Ibrahim NF; Inubushi T; Morikawa S
Ageing Res Rev; 2016 Sep; 30():85-94. PubMed ID: 26772439
[TBL] [Abstract][Full Text] [Related]
2. In vivo detection of amyloid β deposition using ¹⁹F magnetic resonance imaging with a ¹⁹F-containing curcumin derivative in a mouse model of Alzheimer's disease.
Yanagisawa D; Amatsubo T; Morikawa S; Taguchi H; Urushitani M; Shirai N; Hirao K; Shiino A; Inubushi T; Tooyama I
Neuroscience; 2011 Jun; 184():120-7. PubMed ID: 21497641
[TBL] [Abstract][Full Text] [Related]
3. Amyloid imaging using high-field magnetic resonance.
Amatsubo T; Yanagisawa D; Morikawa S; Taguchi H; Tooyama I
Magn Reson Med Sci; 2010; 9(3):95-9. PubMed ID: 20885081
[TBL] [Abstract][Full Text] [Related]
4. Fluoro-substituted and 13C-labeled styrylbenzene derivatives for detecting brain amyloid plaques.
Sato K; Higuchi M; Iwata N; Saido TC; Sasamoto K
Eur J Med Chem; 2004 Jul; 39(7):573-8. PubMed ID: 15236837
[TBL] [Abstract][Full Text] [Related]
5. Preferred features of a fluorine-19 MRI probe for amyloid detection in the brain.
Yanagisawa D; Taguchi H; Ibrahim NF; Morikawa S; Shiino A; Inubushi T; Hirao K; Shirai N; Sogabe T; Tooyama I
J Alzheimers Dis; 2014; 39(3):617-31. PubMed ID: 24246421
[TBL] [Abstract][Full Text] [Related]
6. Contrast-enhanced MR microscopy of amyloid plaques in five mouse models of amyloidosis and in human Alzheimer's disease brains.
Dudeffant C; Vandesquille M; Herbert K; Garin CM; Alves S; Blanchard V; Comoy EE; Petit F; Dhenain M
Sci Rep; 2017 Jul; 7(1):4955. PubMed ID: 28694463
[TBL] [Abstract][Full Text] [Related]
7. Technology Insight: imaging amyloid plaques in the living brain with positron emission tomography and MRI.
Huddleston DE; Small SA
Nat Clin Pract Neurol; 2005 Dec; 1(2):96-105. PubMed ID: 16932505
[TBL] [Abstract][Full Text] [Related]
8. PET of brain amyloid and tau in mild cognitive impairment.
Small GW; Kepe V; Ercoli LM; Siddarth P; Bookheimer SY; Miller KJ; Lavretsky H; Burggren AC; Cole GM; Vinters HV; Thompson PM; Huang SC; Satyamurthy N; Phelps ME; Barrio JR
N Engl J Med; 2006 Dec; 355(25):2652-63. PubMed ID: 17182990
[TBL] [Abstract][Full Text] [Related]
9. Development of amyloid imaging PET probes for an early diagnosis of Alzheimer's disease.
Kudo Y
Minim Invasive Ther Allied Technol; 2006; 15(4):209-13. PubMed ID: 16966133
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of a (18)F-curcumin derivate for β-amyloid plaque imaging.
Rokka J; Snellman A; Zona C; La Ferla B; Nicotra F; Salmona M; Forloni G; Haaparanta-Solin M; Rinne JO; Solin O
Bioorg Med Chem; 2014 May; 22(9):2753-62. PubMed ID: 24702859
[TBL] [Abstract][Full Text] [Related]
11. Current status of PET-imaging probes of β-amyloid plaques.
Koo J; Byun Y
Arch Pharm Res; 2013 Oct; 36(10):1178-84. PubMed ID: 23812777
[TBL] [Abstract][Full Text] [Related]
12. Characterization of AZD4694, a novel fluorinated Abeta plaque neuroimaging PET radioligand.
Juréus A; Swahn BM; Sandell J; Jeppsson F; Johnson AE; Johnström P; Neelissen JA; Sunnemark D; Farde L; Svensson SP
J Neurochem; 2010 Aug; 114(3):784-94. PubMed ID: 20477945
[TBL] [Abstract][Full Text] [Related]
13. [Amyloid-plaque imaging of the brain using PET].
Ossenkoppele R; Tolboom N; Pijnenburg YA; Lammertsma AA; Scheltens P; van Berckel BN
Ned Tijdschr Geneeskd; 2011; 155():A2981. PubMed ID: 21586182
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Styrylbenzene analog- FSB and its affinity to bind parenchymal plaques and tangles in patients of Alzheimer's disease.
Setti SE; Das N; Raymick J; Hanig J; Sarkar S
Metab Brain Dis; 2022 Mar; 37(3):639-651. PubMed ID: 35064472
[TBL] [Abstract][Full Text] [Related]
15. Hybrid PET/MRI enables high-spatial resolution, quantitative imaging of amyloid plaques in an Alzheimer's disease mouse model.
Frost GR; Longo V; Li T; Jonas LA; Judenhofer M; Cherry S; Koutcher J; Lekaye C; Zanzonico P; Li YM
Sci Rep; 2020 Jun; 10(1):10379. PubMed ID: 32587315
[TBL] [Abstract][Full Text] [Related]
16. Feasibility and acceptance of simultaneous amyloid PET/MRI.
Schütz L; Lobsien D; Fritzsch D; Tiepolt S; Werner P; Schroeter ML; Berrouschot J; Saur D; Hesse S; Jochimsen T; Rullmann M; Sattler B; Patt M; Gertz HJ; Villringer A; Claßen J; Hoffmann KT; Sabri O; Barthel H
Eur J Nucl Med Mol Imaging; 2016 Nov; 43(12):2236-2243. PubMed ID: 27435367
[TBL] [Abstract][Full Text] [Related]
17. A novel 18F-labeled pyridyl benzofuran derivative for imaging of β-amyloid plaques in Alzheimer's brains.
Cheng Y; Ono M; Kimura H; Kagawa S; Nishii R; Saji H
Bioorg Med Chem Lett; 2010 Oct; 20(20):6141-4. PubMed ID: 20817524
[TBL] [Abstract][Full Text] [Related]
18. Comparison of imaging biomarkers for Alzheimer's disease: amyloid imaging with [18F]florbetapir positron emission tomography and magnetic resonance imaging voxel-based analysis for entorhinal cortex atrophy.
Tateno A; Sakayori T; Kawashima Y; Higuchi M; Suhara T; Mizumura S; Mintun MA; Skovronsky DM; Honjo K; Ishihara K; Kumita S; Suzuki H; Okubo Y
Int J Geriatr Psychiatry; 2015 May; 30(5):505-13. PubMed ID: 25043833
[TBL] [Abstract][Full Text] [Related]
19. Imaging and Molecular Mechanisms of Alzheimer's Disease: A Review.
Femminella GD; Thayanandan T; Calsolaro V; Komici K; Rengo G; Corbi G; Ferrara N
Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30469491
[TBL] [Abstract][Full Text] [Related]
20. Preliminary PET Study of
Oh SJ; Kim MH; Han SJ; Kang KJ; Ko IO; Kim Y; Park JA; Choi JY; Lee KC; Chi DY; Lee YJ; Kim KM
Mol Pharm; 2017 Sep; 14(9):3114-3120. PubMed ID: 28737945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
